Literature DB >> 16352422

Transferable DHA-1 cephalosporinase in Escherichia coli.

P Giakkoupi1, A Tambic-Andrasevic, S Vourli, J Skrlin, S Sestan-Crnek, L S Tzouvelekis, A C Vatopoulos.   

Abstract

Three Escherichia coli isolates resistant to third-generation cephalosporins but negative for extended-spectrum beta-lactamase production were isolated from hospitalised patients in Zagreb, Croatia, during June 2003 to February 2004. Resistance was due to the inducible production of a DHA-1 cephalosporinase. Each isolate contained an integron-associated bla(DHA-1)-ampR sequence carried by similar-sized plasmids, of which one was self-transferable. Serotyping and polymerase chain reaction typing using ERIC2 primer indicated that the isolates were distinct. This is the first description of DHA beta-lactamase production in E. coli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352422     DOI: 10.1016/j.ijantimicag.2005.09.013

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Genetic and kinetic characterization of the novel AmpC β-lactamases DHA-6 and DHA-7.

Authors:  Francisco José Pérez-Llarena; Laura Zamorano; Frédéric Kerff; Alejandro Beceiro; Patricia García; Elisenda Miró; Nieves Larrosa; Frederic Gómez-Bertomeu; José Antonio Méndez; Juan José González-López; Antonio Oliver; Moreno Galleni; Ferran Navarro; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

2.  Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.

Authors:  Branka Bedenić; Lucija Pešorda; Marija Krilanović; Nataša Beader; Zoran Veir; Silvia Schoenthaler; Daniela Bandić-Pavlović; Sonja Frančula-Zaninović; Ivan Barišić
Journal:  Curr Microbiol       Date:  2022-10-15       Impact factor: 2.343

3.  Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.

Authors:  Branka Bedenić; Nataša Firis; Vesna Elveđi-Gašparović; Marija Krilanović; Krešimir Matanović; Iva Štimac; Josefa Luxner; Jasmina Vraneš; Tomislav Meštrović; Gernot Zarfel; Andrea Grisold
Journal:  Wien Klin Wochenschr       Date:  2016-05-25       Impact factor: 1.704

4.  Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.

Authors:  Qiwen Yang; Hui Wang; Hongli Sun; Hongbin Chen; Yingchun Xu; Minjun Chen
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

5.  Role of AmpR in the High Expression of the Plasmid-Encoded AmpC β-Lactamase CFE-1.

Authors:  Ryuichi Nakano; Akiyo Nakano; Hisakazu Yano; Ryoichi Okamoto
Journal:  mSphere       Date:  2017-08-09       Impact factor: 4.389

6.  Occurrence of bla DHA-1 mediated cephalosporin resistance in Escherichia coli and their transcriptional response against cephalosporin stress: a report from India.

Authors:  Birson Ingti; Deepjyoti Paul; Anand Prakash Maurya; Debajyoti Bora; Debadatta Dhar Chanda; Atanu Chakravarty; Amitabha Bhattacharjee
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-03-21       Impact factor: 3.944

7.  Successful control of the first carbapenem-resistant Klebsiella pneumoniae outbreak in a Chinese hospital 2017-2019.

Authors:  Jiaying Zhu; Qi Li; Xiaoxia Li; Jianbang Kang; Yan Song; Junli Song; Donghong Yin; Jinju Duan
Journal:  Antimicrob Resist Infect Control       Date:  2020-06-22       Impact factor: 4.887

8.  High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study.

Authors:  Peiyao Jia; Ying Zhu; Xue Li; Timothy Kudinha; Yang Yang; Ge Zhang; Jingjia Zhang; Yingchun Xu; Qiwen Yang
Journal:  Front Microbiol       Date:  2021-07-07       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.